|1.||Giamarellos-Bourboulis, Evangelos J: 6 articles (09/2015 - 02/2004)|
|2.||Jacobs, Frédérique: 6 articles (07/2012 - 01/2010)|
|3.||Maire, P: 5 articles (06/2014 - 01/2001)|
|4.||Laterre, Pierre-François: 5 articles (07/2012 - 01/2010)|
|5.||Jarlier, Vincent: 4 articles (11/2015 - 10/2002)|
|6.||Ducher, M: 4 articles (06/2014 - 01/2001)|
|7.||Taccone, Fabio Silvio: 4 articles (01/2013 - 01/2010)|
|8.||Corkery, Kevin: 4 articles (02/2012 - 01/2009)|
|9.||Vincent, Jean-Louis: 4 articles (06/2011 - 01/2010)|
|10.||Hua, Rong: 4 articles (02/2009 - 02/2007)|
03/01/2013 - "xenopi infection, and in this model amikacin-containing regimens were the most effective against M. "
03/01/2011 - "Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. "
05/01/1984 - "In vitro susceptibility tests of synergy were predictive of successful therapy whenever the antibiotic concentrations (free and total) at the infection site exceeded the MBC for both the aminoglycoside alone and the beta-lactam when tested in combination with amikacin."
10/01/2011 - "Further studies should be conducted to determine the aminoglycoside susceptibility profiles of aac(6')-Ib-harboring isolates from various geographic regions and to monitor the therapeutic efficacy of amikacin in infections caused by these isolates."
04/01/1990 - "Correlation of these data with amikacin pharmacokinetic data in volunteers indicated that a daily dose of 15 mg/kg may be effective in the treatment of Escherichia coli and Enterobacter cloacae infections. "
05/01/1991 - "This study in 12 cancer treatment centres across the United States was designed to evaluate the potential for increased resistance to amikacin with unrestricted use. "
02/01/2014 - "Administration schedule and ototoxicity of amikacin in children with cancer."
02/01/2014 - "Invited reply to amikacin ototoxicity in children with cancer: the problem is the administration schedule."
11/01/2013 - "Eligible cancer patients received the aminoglycoside amikacin at Children's Medical Center between 2004 and 2007. "
06/30/1986 - "Several hospitals (Strong Memorial Hospital, University of Maryland Cancer Center, and Minneapolis Veterans Administration Medical Center) have reported either no significant change or a decrease in resistance to amikacin when it was the most frequently used aminoglycoside. "
01/01/2002 - "The use of EIAA in children with febrile neutropenia has been evaluated primarily with amikacin. "
04/01/1996 - "The pharmacokinetics of Amikacin were studied in 56 febrile episodes for 45 patients with severe neutropenia while using the USC*Pack PC Clinical Programs for adaptive control of their dosage regimens [223 drug levels]. "
03/01/2008 - "Amikacin is an aminoglycoside commonly used to provide empirical double gram-negative treatment for febrile neutropenia and other suspected infections. "
11/01/1998 - "The use of amikacin 20 mg/kg daily delivered in a single daily dose is recommended for immunocompromised pediatric patients with fever and neutropenia, in spite of the measured pharmacokinetic differences."
03/01/1982 - "Amikacin sulfate was given to 21 febrile children with neutropenia and cancer for 9 +/- 3 days. "
09/01/1996 - "The efficacy of single daily dose of amikacin has been recently demonstrated in neutropenic children with fever. "
09/01/1996 - "[Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever]."
11/01/1993 - "This study reports on the use of an easily applied Bayesian forecasting programme (OPT; Clydesoft) to predict amikacin dose requirements in 10 patients with haematological disease and neutropenic fever. "
08/01/2001 - "Effect of fever on pharmacokinetics and dosage regimen of intramuscularly administered amikacin in goats."
01/01/1996 - "[Amikacin in single daily doses in children with fever]."
|5.||Urinary Tract Infections (Urinary Tract Infection)
05/17/1993 - "The studies were aimed at the determining the serum amikacin levels during the treatment of urinary tract infection as an attempt to monitor this treatment. "
03/01/1977 - "[Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)]."
06/06/1999 - "Hearing assessment of 14 children suffered from urinary tract infection and treated by amikacin is reported. "
05/17/1993 - "[Monitoring treatment with amikacin for urinary tract infections]."
07/01/1987 - "Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin."
|8.||Anti-Bacterial Agents (Antibiotics)
|1.||Drug Therapy (Chemotherapy)
|3.||Renal Dialysis (Hemodialysis)